ANI Pharmaceuticals Inc.

NASDAQ: ANIP · Real-Time Price · USD
87.42
-2.58 (-2.87%)
At close: Aug 15, 2025, 3:59 PM
87.47
0.06%
After-hours: Aug 15, 2025, 04:10 PM EDT

ANI Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
614.38M 486.82M 316.38M 216.14M
Cost of Revenue
250.21M 181.51M 138.78M 100.61M
Gross Profit
364.17M 305.3M 177.6M 115.53M
Operating Income
584K 46.97M -35.28M -39.79M
Interest Income
n/a n/a n/a n/a
Pretax Income
-22.21M 19.87M -62.66M -56.06M
Net Income
-18.52M 18.78M -47.9M -42.6M
Selling & General & Admin
249.64M 161.7M 124.04M 84.29M
Research & Development
44.58M 34.29M 22.32M 11.37M
Other Expenses
69.36M 62.35M 56.97M 59.66M
Operating Expenses
363.58M 258.33M 203.33M 155.32M
Interest Expense
17.6M 26.94M 28.05M 11.92M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
613.79M 439.85M 351.67M 255.93M
Income Tax Expense
-3.69M 1.09M -14.77M -13.46M
Shares Outstanding (Basic)
19.32M 18M 16.26M 12.6M
Shares Outstanding (Diluted)
19.32M 18.19M 16.26M 12.6M
EPS (Basic)
-1.04 0.95 -3.05 -3.4
EPS (Diluted)
-1.04 0.94 -3.05 -3.4
EBITDA
79.15M 106.6M 33.92M -1.68M
EBIT
11.42M 46.81M -36.91M -48.94M
Depreciation & Amortization
67.73M 59.79M 59.65M 47.25M